UPDATE: Jefferies Lowers PT to $32 on ArthroCare

A report from Jefferies reiterates its Buy rating and lowers its price target from $36 to $32 on ArthroCare ARTC. The report states, “3Q a mixed bag: Sales of $83.3m were below consensus of $87.2mn, but the company is confident new product introductions provide the horsepower to stay the course, and keeps guidance intact at $365-370m. ArthroCare continues to make strides in profitability as adjusted op margins increased 230bp y/y." ARTC closed yesterday at $28.86.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorEarningsNewsPrice TargetAnalyst RatingsJefferies & Company
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!